Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$56.55 - $66.59 $1.31 Million - $1.54 Million
-23,164 Reduced 7.84%
272,250 $15.5 Million
Q4 2023

Feb 09, 2024

BUY
$52.16 - $64.19 $6.98 Million - $8.59 Million
133,769 Added 82.75%
295,414 $18.5 Million
Q3 2023

Nov 13, 2023

BUY
$57.77 - $65.93 $264,817 - $302,223
4,584 Added 2.92%
161,645 $9.34 Million
Q2 2023

Aug 11, 2023

BUY
$60.95 - $75.51 $5.04 Million - $6.25 Million
82,725 Added 111.29%
157,061 $9.78 Million
Q1 2023

May 15, 2023

BUY
$70.23 - $86.01 $1.71 Million - $2.09 Million
24,331 Added 48.66%
74,336 $5.37 Million
Q4 2022

Feb 13, 2023

SELL
$67.18 - $84.11 $2.08 Million - $2.6 Million
-30,929 Reduced 38.22%
50,005 $4.02 Million
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $5.36 Million - $6.71 Million
80,934 New
80,934 $5.39 Million
Q1 2022

May 13, 2022

SELL
$66.02 - $79.71 $3.71 Million - $4.48 Million
-56,242 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$63.34 - $74.11 $3.56 Million - $4.17 Million
56,242 New
56,242 $4.13 Million
Q1 2021

May 13, 2021

SELL
$76.02 - $100.5 $1.41 Million - $1.87 Million
-18,581 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$80.74 - $97.7 $2.24 Million - $2.71 Million
-27,778 Reduced 59.92%
18,581 $1.62 Million
Q3 2020

Nov 06, 2020

BUY
$85.07 - $109.69 $3.94 Million - $5.09 Million
46,359 New
46,359 $4.16 Million
Q2 2020

Aug 07, 2020

SELL
$74.18 - $108.93 $4.76 Million - $6.99 Million
-64,145 Closed
0 $0
Q1 2020

May 08, 2020

BUY
$63.18 - $85.97 $364,927 - $496,562
5,776 Added 9.9%
64,145 $4.7 Million
Q4 2019

Feb 12, 2020

BUY
$73.04 - $95.72 $2.89 Million - $3.79 Million
39,630 Added 211.48%
58,369 $5.1 Million
Q3 2019

Nov 08, 2019

BUY
$72.82 - $86.52 $1.36 Million - $1.62 Million
18,739 New
18,739 $1.39 Million
Q2 2019

Aug 09, 2019

SELL
$73.52 - $88.7 $1.8 Million - $2.18 Million
-24,530 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$63.56 - $88.17 $1.56 Million - $2.16 Million
24,530 New
24,530 $2.11 Million
Q4 2018

Feb 13, 2019

SELL
$58.5 - $69.94 $2.59 Million - $3.1 Million
-44,331 Closed
0 $0
Q3 2018

Nov 09, 2018

SELL
$61.75 - $74.23 $559,084 - $672,078
-9,054 Reduced 16.96%
44,331 $3.06 Million
Q2 2018

Aug 07, 2018

BUY
$60.85 - $83.98 $1.71 Million - $2.36 Million
28,151 Added 111.56%
53,385 $3.58 Million
Q1 2018

May 03, 2018

SELL
$83.06 - $100.98 $268,200 - $326,064
-3,229 Reduced 11.34%
25,234 $2.1 Million
Q4 2017

Feb 09, 2018

BUY
$93.56 - $116.6 $2.66 Million - $3.32 Million
28,463
28,463 $2.7 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.